Active specific immunotherapy for ovarian cancer.
Hudson CN, McHardy JE, Curling OM, English PE, Levin L, Poulton TA, Crowther M, Leighton M.
Hudson CN, et al. Among authors: leighton m.
Lancet. 1976 Oct 23;2(7991):877-9. doi: 10.1016/s0140-6736(76)90539-0.
Lancet. 1976.
PMID: 62114